MARKET PULSE-Endo Health, Pharmerica, Dex Media, Orbitz
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; the Morning Call newsletter, r.reuters.com/vut44v) U.S. stocks were little changed on Tuesday following two days of gains on Wall Street as investors weighed the implications of strong economic data on the path of monetary policy over the next several months. The Dow Jones industrial average fell 9.47 points, or 0.06 percent, to 15,629.65, the S&P 500 lost 2.44 points, or 0.14 percent, to 1,765.49 and the Nasdaq Composite added 3.085 points, or 0.08 percent, to 3,939.676.
** ENDO HEALTH SOLUTIONS INC, $55.89, up 28 pct (11:55 a.m. ET)
The U.S.-based specialty pharmaceutical company said it would buy Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets.
** PHARMERICA CORP, $18.8, up 26 pct (01:07 p.m. ET)
The pharmacy services provider raised its full-year forecast after a strong third quarter when it reported higher gross earnings for every prescription dispensed. Chief Executive Greg Weishar said the company is poised to achieve organic growth in the near future. Pharmerica stock rose to its highest level in over three years on Tuesday morning.
** DEX MEDIA INC, $5.20, down 24 pct (11:50 a.m. ET)
The social and mobile marketing company's third-quarter loss widened to $132 million, or $7.66 per share, from $13 million, or $1.25 per share, a year earlier, as operating costs rose almost 85 percent. The stock was one of the top percentage losers on the Nasdaq, with more than five times its 10-day moving average volumes changing hands. Continued...